Navigation Links
The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA

Needham, Mass. (PRWEB) May 16, 2013

Cambridge Healthtech Institute will host its fifth annual The Bioprocessing Summit from August 19-23, 2013 at the Renaissance Waterfront Hotel in Boston, MA. The ten meetings comprising the Summit provide a close-up look at the current strategies and innovations for optimizing bioprocesses while mitigating risk and ensuring bottom-line quality. Leaders in the field will reveal how their work has resulted in innovative ways to produce biopharmaceuticals with greater specificity and efficiency.

“In this age of rapid innovation, it's critical to keep up with advances and trends, and to exchange ideas with international colleagues. This event is designed to provide insights that optimize tasks at the bench with an emphasis on 'real-world' experience,” says Mary Ruberry, Conference Director of Cambridge Healthtech Institute.

The 2013 Bioprocessing Summit features an expanded roster of meetings. Along with the upstream mainstays of cell culture and cell line development, the Summit now has an expanded formulation foci, plus new meetings delving into early IND strategies. Biomanufacturing and integrating disposables will be explored through the inaugural "Facilities for Manufacturing Biologics" meeting, and the 3rd annual "Scaling Up & Down with Optimized Bioreactors + Disposables" meeting will investigate small-scale models, issues of scale and single-use technologies.

Attendees will hear keynote presentations from Thomas Ryll of Biogen Idec, R. Thomas Warf of BARDA, Palani Palaniappan of Millennium: The Takeda Oncology Company, Florian M. Wurm of EPFL/ExcellGene SA, Ravinder Bhatia of Janssen Research & Development, Jianmei Kochling of Genzyme, a Sanofi company, Donna L. Luisi of Pfizer, Thomas Laue of University of New Hampshire, and Joanne Beck of Shire Human Genetic Therapies.

There are plenty of other highlights as well, including an array of short courses, training seminars, and breakout discussion groups which offer the opportunity to discuss relevant topics in small group settings. This year's exhibit hall will feature an expanding number of exhibit booths and extensive poster presentations.

For more information on The Bioprocessing Summit, visit the event web site at

About Cambridge Healthtech Institute (

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Life Technologies Acquires BAC BV, Expands Capabilities in Bioprocessing
2. BioStorage Technologies Expands its Service Offering to Include Advanced Bioprocessing Solutions
3. TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor
4. Selexis SA to Speak on Next Generation Innovations for Secretion Bottlenecks at the 2013 Protein Engineering Summit (PEGS)
5. Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
6. UCSB summit draws key leaders to discuss innovations in energy efficiency science and technology
7. First Southeast Venture Philanthropy Summit Set In NC
8. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
9. EtQ to Host Life Science Summit on the World of Quality and Global Supply Chain
10. Bayer CropScience Announces Seed Innovation at Pollinator Summit
11. Michigan’s Exotic Automation & Supply to Exhibit at the 2013 Work Truck Show & Green Truck Summit
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):